Young Innovators Shine at Samsung Solve for Tomorrow 2025 Grand Finale

EduHive from Malacca Crowned Champion in Samsung’s STEM Competition KUALA LUMPUR, Malaysia,…

World Gym Corporation (2762.TW) Reports Robust November Revenue Growth and Unveils Ambitious 2026 Strategic Roadmap

TAIPEI, Dec. 10, 2025 /PRNewswire/ — World Gym Corp. (2762.TW), owner and…

Admission To Trading on The London Stock Exchange and Completion of Secondary Listing

PARIS, NEW YORK, and LONDON, Dec. 10, 2025 /PRNewswire/ — The Generation…

Loyalty Juggernaut Ushers in a New Era of Modern Loyalty Tech: Recognized as a Strong Performer in The Forrester Wave™ for Loyalty Platforms, Q4 2025

Elevating loyalty to ignite measurable growth through AI-powered decisioning, smarter engagement, and ecosystem…

Professor Youmin Xi honoured with University of Liverpool Fellowship

SUZHOU, China, Dec. 10, 2025 /PRNewswire/ — Professor Youmin Xi, Executive President of…

Under the Patronage of His Royal Highness the Crown Prince Governor of Riyadh Region Inaugurates MOMENTUM 2025 Development Finance Conference

RIYADH, Saudi Arabia, Dec. 10, 2025 /PRNewswire/ — Under the patronage of…

Cathay Petroleum Strengthens Global Expansion and Reaffirms Commitment to ESG Excellence

SINGAPORE, Dec. 10, 2025 /PRNewswire/ — Cathay Petroleum today announced their commitment and…

Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment

-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT…